The aim of this double-blind , randomized comparative study was to evaluate the efficacy and safety of standardized JC pollen extract in a new oral formulation ( CEDARTOLEN , Torii Pharmaceutical Co. , Ltd. , Tokyo , Japan ) for sublingual immunotherapy ( SLIT ) for JC pollinosis .